| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| FRAXE |
|
fragile site, folic acid type, rare, fra(X)(q28) E
|
|
|
0.636 |
0.462 |
| GBAP1 |
|
glucosylceramidase beta pseudogene 1
|
|
|
0.623 |
0.538 |
| HRES1 |
P13985
|
HTLV-1 related endogenous sequence
|
|
|
0.636 |
0.615 |
| MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
| ATP6 |
P00846
|
ATP synthase F0 subunit 6
|
Transporter
|
|
0.541 |
0.731 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| ND5 |
P03915
|
NADH dehydrogenase, subunit 5 (complex I)
|
Enzyme
|
|
0.531 |
0.769 |
| NEFL |
P07196
|
neurofilament light
|
|
|
0.488 |
0.769 |
| HSP90B2P |
Q58FF3
|
heat shock protein 90 beta family member 2, pseudogene
|
Chaperone
|
|
0.558 |
0.846 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR183 |
|
microRNA 183
|
|
|
0.494 |
0.885 |
| LOC643387 |
|
TAR DNA binding protein pseudogene
|
|
|
0.839 |
0.115 |
| HNRNPA1P10 |
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 10
|
|
|
0.631 |
0.654 |
| LINC01672 |
|
long intergenic non-protein coding RNA 1672
|
|
|
0.462 |
0.846 |
| P2RX5-TAX1BP3 |
|
P2RX5-TAX1BP3 readthrough (NMD candidate)
|
|
|
0.588 |
0.769 |
| ATXN2-AS |
|
ATXN2 antisense RNA
|
|
|
0.890 |
0.192 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| H3P13 |
|
H3 histone pseudogene 13
|
|
|
0.584 |
0.769 |
| ROS1 |
P08922
|
ROS proto-oncogene 1, receptor tyrosine kinase
|
Kinase
|
1.6E-72 |
0.439 |
0.885 |
| SI |
P14410
|
sucrase-isomaltase
|
Enzyme
|
3.9E-60 |
0.569 |
0.692 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| TRPM2 |
O94759
|
transient receptor potential cation channel subfamily M member 2
|
Ion channel
|
9.0E-44 |
0.546 |
0.731 |